SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001753926-24-001693
Filing Date
2024-10-15
Accepted
2024-10-15 11:07:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G g084484_13gs.htm SC 13G 37904
  Complete submission text file 0001753926-24-001693.txt   39490
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Subject) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93002 | Film No.: 241370561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 600 EDGEWATER DRIVE UNIT 402 DUNEDIN FL 34698
Business Address
Cawood Frank Wayne (Filed by) CIK: 0001996432 (see all company filings)

Type: SC 13G